|
|
Conferences & Courses
|
Tackling Drug-Induced and Idiosyncratic Hepatotoxicity
June 6-7, 2012 | Philadelphia, PA
Cambridge Healthtech Institute’s fourth annual conference on Tackling Drug-Induced Idiosyncratic Hepatotoxicity focuses on:
• Strategies for tackling Idiosyncratic Drug-Induced Liver Injury (IDILI)
• In silico tools for predicting hepatotoxicity
• New
|
|
TCGC: The Clinical Genome Conference
June 12-13, 2012 | San Francisco, CA
The free falling cost of whole genome sequencing raises the possibility – some say the inevitability – of applying this revolutionary technology in the clinic.
|
|
|
|
|
|
|
Life Science Media Library
|
Latest Advances in Molecular Pathology DVD
February 20, 2012 |
Escherichia coli has proven its worth as a protein expression platform. Currently, E.coli is not viewed so much as an ‘alternative’ platform, but as a viable choice for achieving high-level expression of human genes and proteins at a reasonable cost.
|
EMR/EHRs: Utilization of Electronic Health Record Data DVD
February 6, 2012 |
Escherichia coli has proven its worth as a protein expression platform. Currently, E.coli is not viewed so much as an ‘alternative’ platform, but as a viable choice for achieving high-level expression of human genes and proteins at a reasonable cost.
|
Utilization of EHRs/EMRs to Further Drug & Disease Related Res DVD
April 12, 2011 |
The American Reinvestment and Recovery Act, EHR-incentive rule and ‘Meaningful use objective/measures’ guidelines have the potential to accelerate the utilization of EHR/EMRs by healthcare providers and institutions. Patients, Providers, Manufacturers and Payors are expected to benefit from improved public health decision-support delivered through effective use of this type of evidence. In this workshop, we discuss the potential benefits and risks involved in mining information outside of controlled trials to create insights on diseases, drugs, and patient populations.
|
|
|
|
Publications, Reports, & Whitepapers
|
New Trends in Preventive and Therapeutic Vaccines
New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects, published by Insight Pharma Reports provides an analytical snapshot of the current state of the vaccine industry, its development efforts, and an outlook to 2020.
|
The Antiviral Pipeline: HIV, HCV, and Influenza
The Antiviral Pipeline: HIV, HCV, and Influenza Report,an Insight Pharma Report, explores clinical development activities and market drivers in these areas. Resistance to antiviral drugs will always pose a threat and there is a constant need to update the development pipeline and consider novel ways to combine different antiviral drugs.
|
Data Mining in Drug Development and Translational Medicine
This report explores the pharmacogenomic (PGx) realm of personalized medicine, analyzing current R&D and market trends related to the use of genetic information to predict how well patients will respond to certain drugs. Drivers of PGx, applications of PGx in drug development, industry experiences with PGx and lessons that have been learned, type of evidence needed to establish clinical utility, challenges to moving PGx forward, survey results and expert views on utilization of PGx are considered.
|
|
|
|
|